Hypo-osmotic Stress Drives IL-33 Production in Human Keratinocytes-An Epidermal Homeostatic Response.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
01 2019
Historique:
received: 27 04 2018
revised: 28 06 2018
accepted: 16 07 2018
pubmed: 19 8 2018
medline: 2 11 2019
entrez: 19 8 2018
Statut: ppublish

Résumé

Although inflammation has traditionally been considered a response to either exogenous pathogen-associated signals or endogenous signals of cell damage, other perturbations of homeostasis, generally referred to as stress, may also induce inflammation. The relationship between stress and inflammation is, however, not well defined. Here, we describe a mechanism of IL-33 induction driven by hypo-osmotic stress in human keratinocytes and also report interesting differences when comparing the responsiveness of other inflammatory mediators. The induction of IL-33 was completely dependent on EGFR and calcium signaling, and inhibition of calcium signaling not only abolished IL-33 induction but also dramatically changed the transcriptional pattern of other cytokines upon hypo-osmotic stress. IL-33 was not secreted but instead showed nuclear sequestration, conceivably acting as a failsafe mechanism whereby it is induced by potential danger but released only upon more extreme homeostatic perturbations that result in cell death. Finally, stress-induced IL-33 was also confirmed in an ex vivo human skin model, translating this mechanism to a potential tissue-relevant signal in the human epidermis. In conclusion, we describe hypo-osmotic stress as an inducer of IL-33 expression, linking cellular stress to nuclear accumulation of a strong proinflammatory cytokine.

Identifiants

pubmed: 30120934
pii: S0022-202X(18)32476-X
doi: 10.1016/j.jid.2018.07.023
pii:
doi:

Substances chimiques

Cytokines 0
Interleukin-33 0
RNA 63231-63-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

81-90

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Wojciech Pietka (W)

K.G. Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.

Denis Khnykin (D)

K.G. Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.

Vibeke Bertelsen (V)

Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.

Astrid Haaskjold Lossius (AH)

K.G. Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.

Tor Espen Stav-Noraas (TE)

K.G. Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.

Johanna Hol Fosse (J)

K.G. Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.

Hilde Kanli Galtung (HK)

Department of Oral Biology, University of Oslo and Oslo University Hospital, Oslo, Norway.

Guttorm Haraldsen (G)

K.G. Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway. Electronic address: gharalds@rr-research.no.

Olav Sundnes (O)

K.G. Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Rheumatology, Dermatology and Infectious Diseases, University of Oslo and Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH